BOT 2.63% 37.0¢ botanix pharmaceuticals ltd

Ann: FDA Approves Sofdra, page-164

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. WBA
    2,357 Posts.
    lightbulb Created with Sketch. 417
    If you research DXB from 11 March on an efficatiecy announcement to a TH and a capital raise on 12 March to the SP today, you'll find a 100% gain in a little over 3 months...
    Both DXB and BOT feature heavily as broker tips.

    We will now soon what the purpose of the raise is soon.

    Potentially they may be considering a strategic tie up with Kaken (Ecclock) for advancement into Asia as a scenario.......after all they were there March time....
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
37.0¢
Change
-0.010(2.63%)
Mkt cap ! $671.1M
Open High Low Value Volume
38.0¢ 38.0¢ 37.0¢ $1.949M 5.207M

Buyers (Bids)

No. Vol. Price($)
7 163455 37.0¢
 

Sellers (Offers)

Price($) Vol. No.
37.5¢ 33207 2
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.